Serum Institute Of India
Serum Institute of India is a manufacturer of immunobiological drugs including vaccines in India. It was founded by Cyrus Poonawalla in 1966.The company is the world's largest vaccine producer by number of doses produced. It is currently developing an intra-nasal swine flu vaccine.
Serum Institute all set to begin phase 3 trials of Covid-19 vaccine
Serum Institute of India (SII) is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford University at Sassoon General Hospital in Pune, the hospital administration said on Saturday.
DCGI gives nod to Serum Institute to restart phase 2,3 trials for COVID-19 vaccine
The Drugs Controller General of India (DCGI) has allowed Serum Institute of India (SII) to restart its phase two and three clinical trials for COVID-19 vaccine after the pharma major submitted the recommendations of the Data Safety Monitoring Board (DSMB), UK and DSMB India and requested permission to restart enrolment in the subject clinical trial of the vaccine being developed by AstraZeneca and Oxford University.
SII to resume Covid vaccine trials once DCGI gives nod
New Delhi, Sep 12 Serum Institute of India (SII) said on Saturday it will resume trials in India ...
SII asked to submit approvals from DSMB India & UK to resume vax trial
New Delhi, Sep 12 The Drug Controller General of India (DCGI) has directed the Serum Institute of India ...
DCGI directs Serum Institute to suspend any new recruitment in phase 2, 3 COVID-19 vaccine clinical trials
The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders.
DCGI directs Serum Institute to suspend any new recruitment in phase 2, 3 COVID-19 vaccine clinical trials
The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend any new recruitment in phase 2 and 3 clinical trials for COVID-19 vaccine till further orders.
DCGI sends show cause notice to Serum Institute for not pausing trial of COVID-19 vaccine
The Drugs Regulator General of India (DCGI) has issued a show-cause notice to pharma giant Serum Institute of India (SII) asking for an explanation as to why the ongoing clinical trial of Covishield vaccine candidate has not been suspended till doubts about patient safety are cleared.
India will have 'approved' vaccine by 2021 Q1: Bernstein Research
New York, Aug 28 India is on course to have an "approved" vaccine within the first quarter of ...
Status of various candidate vaccines for Covid-19 presented before govt: Health Ministry
The domestic pharma giants on Monday presented the current status of various candidate vaccines for COVID-19 to the central government.
Serum Institute to price Covid vaccine at less than Rs 250/dose
New Delhi, Aug 7 The Serum Institute of India would introduce candidate vaccines from AstraZeneca and Novavax for ...
Most Popular Stories
Farmhouse manager exposes Rhea, claims she used Sushant's money for her own expenses
Ashley Tisdale is expecting her first child with husband Christopher French
Customs register two cases against Kerala govt for accepting consignments by UAE for personal use
China military threat is 'very real': Taiwan
